Biotech · Private company
Allena Pharmaceuticals
Track this companyFree. Adds Allena Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- ALLN-177Phase 3 · Enteric HyperoxaluriaClinicalTrials.gov · fetched Nov 12, 2026
- ReloxaliasePhase 3 · Enteric HyperoxaluriaClinicalTrials.gov · fetched Nov 12, 2026
- ALLN-177Phase 2 · HyperoxaluriaClinicalTrials.gov · fetched Nov 12, 2026
- ALLN-346Phase 2 · HyperuricemiaClinicalTrials.gov · fetched Nov 12, 2026
- Test MealSecondary HyperoxaluriaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney DiseasePHASE2 · TERMINATED · started Sep 2, 2022ClinicalTrials.gov NCT04987294 · fetched Nov 12, 2026
- An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)PHASE2 · COMPLETED · started Jul 16, 2021ClinicalTrials.gov NCT04987242 · fetched Nov 12, 2026
- Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)PHASE1 · COMPLETED · started Apr 21, 2021ClinicalTrials.gov NCT04829435 · fetched Nov 12, 2026
- ALLN-346 Single Ascending Dose (SAD) Study in Healthy VolunteersPHASE1 · COMPLETED · started Sep 2, 2020ClinicalTrials.gov NCT04236219 · fetched Nov 12, 2026
- Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric HyperoxaluriaPHASE3 · TERMINATED · started Aug 26, 2019ClinicalTrials.gov NCT03847090 · fetched Nov 12, 2026
- Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and HyperoxalemiaPHASE2 · COMPLETED · started Jul 17, 2018ClinicalTrials.gov NCT03391804 · fetched Nov 12, 2026
- Evaluate ALLN-177 in Patients With Enteric HyperoxaluriaPHASE3 · COMPLETED · started May 21, 2018ClinicalTrials.gov NCT03456830 · fetched Nov 12, 2026
- A Pilot Study of Oxalate Absorption in Secondary HyperoxaluriaNA · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT03095885 · fetched Nov 12, 2026
- Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With HyperoxaluriaPHASE2 · COMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02289755 · fetched Nov 12, 2026